CRISPR-based cancer therapies likely to be a disruptive technology in healthcare: GlobalData
Three leading companies racing to bring CRISPR therapies to the clinic are CRISPR Therapeutics, Intellia Therapeutics and Editas…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Pharma Intelligence
China continues to lead high value oncology deals in APAC: GlobalData
High-value deals have dominated the Asia-Pacific (APAC) pharma strategic partnership landscape in 2020. Within the region, China…
Is Women’s Health gaining momentum?
In Express Pharma’s Women’s Day Special issue, some industry observers and pharma stakeholders share insights on opportunities,…
COVID-19 expedites India’s focus on innovation within pharma: GlobalData
According to the Global Innovation Index, India has moved up four places to 48 in the overall ranking across sectors in 2020
India’s CMO market is hotbed for global PE investment: GlobalData
Indian pharma companies are more likely to engage in contract/excess capacity API manufacture than companies in the other small…
COVID-19 effect will boost infectious disease drug approvals
It will present more opportunities to CMOs informs GlobalData, highlighting that in early May, there were 312 novel pipeline drugs…